Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes

Name: Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes
License: Public Domain

AstraZeneca

ClinicalTrials.gov · Datasets · License: Public Domain

type 2 diabetes mellitus

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 201739
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.